中文 | English
Return
Total: 29 , 1/3
Show Home Prev Next End page: GO
MeSH:(Proto-Oncogene Proteins c-mdm2/genetics*)

1.Diagnostic value of MDM2 RNA in situ hybridization in atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma.

Chen CHEN ; Xin HE ; Wen Yi JING ; Yan QIU ; Min CHEN ; Tian You LUO ; Xiao Yu LIU ; Hui Juan CHEN ; Hong Ying ZHANG ; Hong BU

Chinese Journal of Pathology 2022;51(3):190-195

3.Relationship between the expression of murine double minute 2 oncogene and non-Hodgkin lymphoma in childhood.

Zhuang LIU ; Gui-fang LONG ; Yun-li HAN ; Hong-ying WEI

Chinese Journal of Pediatrics 2004;42(12):928-931

4.Functional characterization of human oncoprotein gankyrin in Zebrafish.

So Yeon KIM ; Wonhee HUR ; Jung Eun CHOI ; Daniel KIM ; Jin Sang WANG ; Hye Yeon YOON ; Lian Shu PIAO ; Seung Kew YOON

Experimental & Molecular Medicine 2009;41(1):8-16

5.Mouse models of Mdm2 and Mdm4 and their clinical implications.

Shunbin XIONG

Chinese Journal of Cancer 2013;32(7):371-375

7.Myxiod pleomorphic liposarcoma: a clinicopathological and molecular genetic analysis of six cases.

Xin Chun ZHENG ; Hai Jian HUANG ; Zhi Jie YOU ; Jie LIN ; Xiao Yan CHEN ; Dingrong ZHONG

Chinese Journal of Pathology 2022;51(8):738-742

8.Clinical value of fluorescence in situ hybridization with MDM2 and DDIT3 probe in diagnosis of liposarcoma.

Wei WANG ; Xin LI ; Ping LIU ; Ying DONG

Journal of Peking University(Health Sciences) 2023;55(2):228-233

9.Paratesticular liposarcoma: the clinicopathological features of nineteen cases.

Shao Min YANG ; Ruo Chen WU ; Shuang Shuang QI ; Jiang Feng YOU

Chinese Journal of Pathology 2022;51(1):17-22

10.The relationship and clinicopathological significance of Numb,MDM2 and p53 expression in human pancreatic cancer.

Weiwei SHENG ; Ming DONG ; Jianping ZHOU ; Xin LI ; Qingfeng LIU ; Qi DONG ; Feng LI

Chinese Journal of Surgery 2014;52(9):675-681

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 29 , 1/3 Show Home Prev Next End page: GO